Outro

targeting the mechanisms of treatment resistance in cancer with Nicholas Goldner | 222

0

0

0 Visualizações· 09/26/23

cancer – Learning with Lowell
0 Assinantes

Dentro

Nicholas Goldner, PhD, is the CEO and co-founder of resistanceBio, where he leads a mission to outsmart cancer by developing innovative therapies targeting treatment resistance mechanisms. He also serves as a venture partner at Pioneer... Source

Mostre mais

0 Comentários

A seguir

Reprodução automática

Casa

Explore mais

Ajuda